Acuta Capital Partners’s CAS Medical Systems, Inc. CASM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q2 | – | Sell |
-5,263,508
| Closed | -$12.8M | – | 43 |
|
|
2019
Q1 | $12.8M | Hold |
5,263,508
| – | – | 6.08% | 4 |
|
|
2018
Q4 | $8.42M | Hold |
5,263,508
| – | – | 6.42% | 4 |
|
|
2018
Q3 | $12M | Hold |
5,263,508
| – | – | 4.28% | 8 |
|
|
2018
Q2 | $10.3M | Buy |
5,263,508
+46,510
| +0.9% | +$69.3K | 1.83% | 13 |
|
|
2018
Q1 | $6.57M | Buy |
5,216,998
+56,998
| +1% | +$64.3K | 1.07% | 20 |
|
|
2017
Q4 | $3.97M | Buy |
5,160,000
+66,724
| +1% | +$48.8K | 0.75% | 23 |
|
|
2017
Q3 | $4.69M | Buy |
5,093,276
+333,125
| +7% | +$341K | 0.84% | 26 |
|
|
2017
Q2 | $5.52M | Buy |
4,760,151
+337,651
| +8% | +$386K | 1.55% | 16 |
|
|
2017
Q1 | $6.41M | Buy |
4,422,500
+242,662
| +6% | +$369K | 1.52% | 16 |
|
|
2016
Q4 | $6.73M | Buy |
4,179,838
+334,473
| +9% | +$562K | 2.5% | 17 |
|
|
2016
Q3 | $6.65M | Buy |
3,845,365
+344,763
| +10% | +$598K | 2.5% | 13 |
|
|
2016
Q2 | $6.44M | Buy |
3,500,602
+821,849
| +31% | +$1.54M | 3.1% | 8 |
|
|
2016
Q1 | $3.8M | Buy |
2,678,753
+126,950
| +5% | +$206K | 2.13% | 15 |
|
|
2015
Q4 | $4.52M | Buy |
2,551,803
+4,504
| +0.2% | +$6.36K | 2.16% | 17 |
|
|
2015
Q3 | $3.18M | Buy |
2,547,299
+191,944
| +8% | +$227K | 1.84% | 17 |
|
|
2015
Q2 | $3.02M | Buy |
2,355,355
+195,355
| +9% | +$254K | 1.86% | 19 |
|
|
2015
Q1 | $2.88M | Buy |
2,160,000
+1,637,533
| +313% | +$2.36M | 2.43% | 15 |
|
|
2014
Q4 | $862K | Buy |
+522,467
| New | +$924K | 0.58% | 47 |
|
Acuta Capital Partners's CASM Position: Q2 2019 in Review
Acuta Capital Partners sold out of CAS Medical Systems, Inc. (CASM) in Q2 2019, closing a stake of 5,263,508 shares — an estimated $12.8M sold.
Acuta Capital Partners first reported a position in CASM in Q4 2014 and held it in 18 quarters. The position peaked at $12.8M in Q1 2019. 0 funds tracked by Wall St. Rank hold CASM as of Q2 2019.
- Acuta Capital Partners reported no remaining CAS Medical Systems, Inc. position as of Q2 2019 after selling out during the quarter.
- Acuta Capital Partners sold 5,263,508 CAS Medical Systems, Inc. shares in Q2 2019, an estimated $12.8M.
- Acuta Capital Partners first reported a position in CAS Medical Systems, Inc. in Q4 2014 and held it in 18 quarters.
- Acuta Capital Partners's CAS Medical Systems, Inc. position peaked at $12.8M in Q1 2019.
- 0 funds tracked by Wall St. Rank held CAS Medical Systems, Inc. as of Q2 2019.
Based on Acuta Capital Partners's 13F filing for Q2 2019, filed 14 Aug 2019.